JPWO2023106261A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023106261A5 JPWO2023106261A5 JP2023566309A JP2023566309A JPWO2023106261A5 JP WO2023106261 A5 JPWO2023106261 A5 JP WO2023106261A5 JP 2023566309 A JP2023566309 A JP 2023566309A JP 2023566309 A JP2023566309 A JP 2023566309A JP WO2023106261 A5 JPWO2023106261 A5 JP WO2023106261A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- promoter
- associated virus
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021197789 | 2021-12-06 | ||
| PCT/JP2022/044719 WO2023106261A1 (ja) | 2021-12-06 | 2022-12-05 | 鉄蓄積性神経変性疾患の治療のための組換えアデノ随伴ウイルスベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023106261A1 JPWO2023106261A1 (https=) | 2023-06-15 |
| JPWO2023106261A5 true JPWO2023106261A5 (https=) | 2024-10-10 |
Family
ID=86730357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566309A Pending JPWO2023106261A1 (https=) | 2021-12-06 | 2022-12-05 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250312484A1 (https=) |
| EP (1) | EP4446419A1 (https=) |
| JP (1) | JPWO2023106261A1 (https=) |
| WO (1) | WO2023106261A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| ES2336887T5 (es) | 2000-03-30 | 2019-03-06 | Whitehead Inst Biomedical Res | Mediadores de interferencia por ARN específicos de secuencias de ARN |
| WO2003093479A1 (en) | 2002-05-01 | 2003-11-13 | University Of Florida Research Foundation, Inc. | Improved raav expression systems and methods for enhancing transduction of mammalian neural cells |
| ES2714007T3 (es) | 2007-04-09 | 2019-05-24 | Univ Florida | Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso |
| WO2012057363A1 (ja) | 2010-10-27 | 2012-05-03 | 学校法人自治医科大学 | 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン |
| WO2013174760A1 (en) | 2012-05-25 | 2013-11-28 | Deutsches Krebsforschungszentrum | Optimized aav-vectors for high transduction rates in dendritic cells |
-
2022
- 2022-12-05 JP JP2023566309A patent/JPWO2023106261A1/ja active Pending
- 2022-12-05 US US18/716,379 patent/US20250312484A1/en active Pending
- 2022-12-05 WO PCT/JP2022/044719 patent/WO2023106261A1/ja not_active Ceased
- 2022-12-05 EP EP22904189.2A patent/EP4446419A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lundberg et al. | Applications of lentiviral vectors for biology and gene therapy of neurological disorders | |
| JP5907579B2 (ja) | 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン | |
| TWI835761B (zh) | 工程化dna結合蛋白 | |
| CN117321213A (zh) | 具有优选表达水平的腺相关病毒组合物 | |
| CN102459611B (zh) | 神经退行性疾病的基因治疗 | |
| CN107532173A (zh) | 靶向中枢神经系统的aav载体 | |
| KR20240110849A (ko) | Aadc/gdnf 폴리뉴클레오티드 및 이의 파킨슨병 치료에 있어서의 용도 | |
| Carlsson et al. | Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy | |
| CN113227126A (zh) | 成纤维细胞生长因子21(fgf21)基因治疗 | |
| JP7334996B2 (ja) | グルコーストランスポーター1発現用アデノ随伴ウイルスベクター | |
| JPWO2023106261A5 (https=) | ||
| JP7641911B2 (ja) | 新型の酵素組成物 | |
| CN117106825B (zh) | 用于治疗帕金森病的基因治疗载体及其用途 | |
| CA3197316A1 (en) | Neurod1 and dlx2 vector | |
| WO2021031025A1 (zh) | Ptbp1抑制剂在预防和/或治疗神经退行性疾病中的应用 | |
| ES2883358T3 (es) | Gen Dgkk recombinante para terapia génica del síndrome de X frágil | |
| US20220098616A1 (en) | ISL1 and LHX3 VECTOR | |
| US20220098617A1 (en) | Ascl1 vector | |
| US20260002176A1 (en) | Adeno-associated virus gene therapy products and methods | |
| HK40095433A (zh) | 用於治疗帕金森病的基因治疗载体及其用途 | |
| HK40095433B (zh) | 用於治疗帕金森病的基因治疗载体及其用途 | |
| CN121866337A (zh) | 经修饰的腺相关病毒载体及其在治疗神经疾病中的用途 | |
| TW202415773A (zh) | 用於治療神經系統疾病的aav基因療法 | |
| WO2025090858A1 (en) | Methods for identifying aav capsid variants with desired characteristics | |
| CN116710566A (zh) | Neurod1载体 |